Core Laboratories Inc. (CLB)
After hours:
| Previous close | 16.99 |
| Open | 16.79 |
| Bid | 16.00 x 900 |
| Ask | 17.98 x 900 |
| Day's range | 16.52 - 16.96 |
| 52-week range | 13.82 - 27.95 |
| Volume | |
| Avg. volume | 429,012 |
| Market cap | 792.828M |
| Beta (5Y monthly) | 2.43 |
| PE ratio (TTM) | 32.41 |
| EPS (TTM) | 0.51 |
| Earnings date | 30 Jan 2024 - 05 Feb 2024 |
| Forward dividend & yield | 0.04 (0.24%) |
| Ex-dividend date | 09 Feb 2024 |
| 1y target est | 19.38 |
PR NewswireCORE LAB REPORTS FIRST QUARTER 2024 RESULTS
Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported first quarter 2024 revenue of $129,600,000. Core's operating income was $8,600,000, with diluted earnings per share ("EPS") of $0.07, all in accordance with U.S. generally accepted accounting principles ("GAAP"). Operating income, ex-items, a non-GAAP financial measure, was $14,900,000, yielding operating margins of 12%, and EPS, ex-items, of $0.19. During the first quarter of 2024, the Company recorded: 1) appr
ZacksKinder Morgan (KMI) Beats on Q1 Earnings, Hikes Dividend
Kinder Morgan's (KMI) Q1 earnings gain from increased financial contributions from the Natural Gas Pipelines, Products Pipelines and Terminals business segments.
ZacksSunoco (SUN) Proceeds With Strategic Portfolio Optimization
Despite the significant structural changes, Sunoco (SUN) maintains its financial outlook for 2024. The company projects 2024 adjusted EBITDA between $975 million and $1 billion.
